In the Q-SRP group, the mean IL-1β serum level was 96.62 pgr/ml before treatment, which decreased to 70.15 and 61.61 pgr/ml at 2- and 4-month intervals, respectively after treatment. This evidence concerns the gene IL1B and short rib dysplasia.